Practical Guidance on the Use of Lurasidone for the Treatment of Adults with Schizophrenia

INTRODUCTION: Lurasidone is an atypical antipsychotic that was approved in Europe in 2014 for the treatment of schizophrenia in adults aged ≥ 18 years. Clinical experience with lurasidone in Europe is currently limited, and there is therefore a need to provide practical guidance on using lurasidone...

Descripción completa

Detalles Bibliográficos
Autores principales: Javed, Afzal, Arthur, Holger, Curtis, Logos, Hansen, Lars, Pappa, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858892/
https://www.ncbi.nlm.nih.gov/pubmed/31098889
http://dx.doi.org/10.1007/s40120-019-0138-z

Ejemplares similares

Ejemplares similares